Therapeutics News and Research

RSS

Direct contact with lymphatic endothelial cells promotes melanoma metastasis

Despite the declining death rates for many individual cancer types, mortality for a few cancers has stabilized or even increased. One of these is melanoma due to its ability, in later stages, to spread to other parts of the body.

2 May 2018

Illinois Department of Commerce and Economic Opportunity approves development of new research park in North Chicago

The Illinois Department of Commerce and Economic Opportunity recently approved the expansion of a state enterprise zone, designed to stimulate economic growth and community revitalization at the local level, to include North Chicago, IL-based

28 Apr 2018

New MoU signed to accelerate advancement of early-stage life sciences start-ups

The Wistar Institute and Ben Franklin Technology Partners of Southeastern Pennsylvania (Ben Franklin), a nonprofit conglomerate of partners providing direct/seed funding, mentorship and networks to strengthen enterprise development, have signed a Memorandum of Understanding (MoU) to accelerate the advancement of early-stage life sciences start-ups coming out of Wistar.

28 Apr 2018

Study identifies unique bacterial behavioral response to certain antibiotics

In a new study published in the Journal of Biological Chemistry, researchers from the University of Notre Dame and the University of Illinois at Urbana-Champaign have found that the bacterium Pseudomonas aeruginosa, a pathogen that causes pneumonia, sepsis and other infections, communicates distress signals within a group of bacteria in response to certain antibiotics.

27 Apr 2018

Study shows nitric oxide inhibits S. aureus bacteria from transforming to its virulent form

According to the U.S. Centers for Disease Control and Prevention, about one in three humans carries Staphylococcus aureus, or "staph," in our noses, and 2 percent of us carry the dreaded methicillin-resistant (MRSA) strain that thwarts common antibiotics.

27 Apr 2018

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder.

27 Apr 2018

Researchers discover significant distortions in leading genetics study method

Many conclusions drawn from a common approach to the study of human genetics could be distorted because of a previously overlooked phenomenon, according to researchers at the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai and collaborators from Massachusetts General Hospital and the Broad Institute.

25 Apr 2018

Key signaling protein in Huntington's disease found to have deleterious effects on heart function, shows study

Researchers investigating a key signaling protein in Huntington's disease describe deleterious effects on heart function, going beyond the disease's devastating neurological impact.

25 Apr 2018

Repurposing existing antiviral drugs for multiple infections

Zika virus. Ebola virus. Influenza. SARS and MERS corona viruses. Existing and emerging viral diseases are an increasing problem, particularly in developing countries. The World Health Organization has called for better control of viral diseases, but developing drugs for this purpose can be challenging.

25 Apr 2018

New app could improve safety of cannabis use

Although cannabis, also known as marijuana, has been shown to impair memory, reaction time and attention, it is difficult to assess this impairment in a natural setting. Researchers have developed a prototype app called 'Am I Stoned' that could help cannabis users understand how the drug is affecting them through a series of phone-based tasks.

25 Apr 2018

Researchers find role of iron storage gene in slowing down prostate cancer growth

An abnormally high level of iron in the body is associated with prostate cancer, and researchers from the Cancer Science Institute of Singapore at the National University of Singapore may have uncovered the mechanism to explain this link.

24 Apr 2018

NuProbe to commercialize Wyss Institute's new technology to facilitate precision medicine

NuProbe Global will commercialize the Wyss Institute's DNA nanotechnology-based variant-detecting method as a fast, low-cost and multiplexed molecular diagnostic for different disease areas, including cancer and infectious diseases.

24 Apr 2018

New compound could offer pain-relieving properties without risk of addiction

Researchers at the University of Michigan have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.

24 Apr 2018

Studies offer leads for new approaches to treat neurological problems

Technological advances have ushered in a new era of discovery in neuroscience. The Experimental Biology 2018 meeting will feature an array of research findings on the brain and nervous system.

23 Apr 2018

Researchers develop new vaccine to help people overcome bath salts abuse

Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones, or bath salts. The vaccine blunts the illegal stimulant's effects on the brain, which could help recovering drug users who experience a relapse.

23 Apr 2018

Innovative research could lead to new ways to treat, prevent cancer

Research into cancer can provide new insight into how this disease works and how it can be stopped. The Experimental Biology 2018 meeting will showcase innovative research that could lead to new ways to treat and prevent cancer.

23 Apr 2018

Experimental compound reduces destructive inflammation to improve stroke outcome

An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.

20 Apr 2018

NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees

NovaDigm Therapeutics, a company developing innovative immuno-therapeutics and preventative vaccines for fungal and bacterial infections, today announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of military trainees.

19 Apr 2018

Finding the 'keyhole' to beat obesity at the cellular level

An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.

19 Apr 2018

Study reports promising novel approach to treat therapy resistant pediatric brain tumors

Researchers used an experimental molecular therapy in preclinical laboratory tests to effectively treat several types of deadly pediatric brain cancer and now propose advancing the treatment to clinical testing in children.

17 Apr 2018

Therapeutics News and Research

Direct contact with lymphatic endothelial cells promotes melanoma metastasis

Illinois Department of Commerce and Economic Opportunity approves development of new research park in North Chicago

New MoU signed to accelerate advancement of early-stage life sciences start-ups

Study identifies unique bacterial behavioral response to certain antibiotics

Study shows nitric oxide inhibits S. aureus bacteria from transforming to its virulent form

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Researchers discover significant distortions in leading genetics study method

Key signaling protein in Huntington's disease found to have deleterious effects on heart function, shows study

Repurposing existing antiviral drugs for multiple infections

New app could improve safety of cannabis use

Researchers find role of iron storage gene in slowing down prostate cancer growth

NuProbe to commercialize Wyss Institute's new technology to facilitate precision medicine

New compound could offer pain-relieving properties without risk of addiction

Studies offer leads for new approaches to treat neurological problems

Researchers develop new vaccine to help people overcome bath salts abuse

Innovative research could lead to new ways to treat, prevent cancer

Experimental compound reduces destructive inflammation to improve stroke outcome

NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees

Finding the 'keyhole' to beat obesity at the cellular level

Study reports promising novel approach to treat therapy resistant pediatric brain tumors

Advancing therapeutic biopolymer development eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News